1. Meij, J.T.A., Haselton, C.L., Hillman, K.L., Dhanasekaran, M., Ebadi, M. and Yu, Lei. 2004. Differential mechanisms of nitric oxide- and peroxynitrite-induced cell death. Mol. Pharmac. 66:1043-1053.
2. Romanick, M.A., S.G. Rakoczy and H.M. Brown-Borg. 2004. Long-lived Ames dwarf mouse exhibits increased antioxidant defense in skeletal muscle. Mechanisms of Ageing Development 125(4):269-281.
3. Sondag, CM and Combs, CK. 2004. Amyloid precursor protein mediates proinflammatory activation of monocytic lineage cells. J Biol Chem. 279:14456-14463.
4. Anderson C.M., F. Lopez., H.Y. Zhang, K. Pavlish and J.N. Benoit. 2005. Reduced utero-placental perfusion alters uterine arcuate artery function in the pregnant Sprague- Dawley rat. Biology of Reproduction, 72(3): 762-766.
5. Anderson C.M., H.Y. Zhang, F. Lopez, K. Pavlish and J.N. Benoit. 2005. Characterization of changes in leptin and leptin receptors in a rat model of preeclampsia. Am. J. Obstetrics & Gynecology, 193(1): 267-72.
6. Hillman K.L., Doze V.A. and *Porter J.E. 2005. Functional Characterization of the ß-AR Subtypes Expressed by CA1 Pyramidal Cells in the Rat Hippocampus J. Pharmacol. Exp. Therap., 314:561.
7. Hillman K.L., Knudson C.A., Carr P.A., Doze V.A. and *Porter J.E. 2005. Adrenergic Receptor Characterization of CA1 Hippocampal Neurons Using Real Time Single Cell RT-PCR. Brain Res. Mol. Brain Res. 139:267.
8. Jurgens C.W.D., Rau K.E., Knudson C.A., King J.D., Carr P.A., *Porter J.E. and Doze V.A. 2005. ß1 Adrenergic Receptor-Mediated Enhancement of Hippocampal CA3 Network Activity. J. Pharmacol. Exp. Therap., 314:552-560.
9. Jurgens CWD, Boese SJ, King JD, Pyle SJ, Porter JE, Doze VA. 2005. Adrenergic receptor modulation of hippocampal CA3 network activity. Epilepsy Research 66, 117-128.
10. Shepel, P.N., D. Ramonet, P. Stevens, and J.D. Geiger. 2005. Purine level regulation during energy depletion associated with graded excitatory stimulation in brain. Neurological Research 27: 139-148.
11. Zhang, H.Y., H. Yu, Y. Shirasawa, X. Chen and J.N. Benoit. 2005. Impaired agonist dependent myosin phosphorylation and decreased RhoA expression in the rat portal hypertensive mesenteric vasculature. Am. J. Physiol., 288(4): G603-G608.
12. Anderson, C.M., F. Lopez, A. Zimmer and J. N. Benoit. 2006. Placental insufficiency leads to developmental hypertension and mesenteric artery dysfunction in two generations of Sprague-Dawley rat offspring. Biol. Reprod. 74(3): 538-44.
13. Anderson, C.M., F. Lopez, H.Y. Zhang, Y. Shirasawa, K. Pavlish and J.N. Benoit. 2006. Mesenteric vascular responsiveness in a rat model of pregnancy-induced hypertension. Exp. Biol. Med. 231(8): 1398-402.
14. Austin, S.A., Floden, A.M., Murphy, E.J., and Combs, C.K. 2006. Alpha-synuclein expression modulated microglial activation phenotype J. Neurosci. 26(41), pp. 10558-10563.
15. Banerjee S., Evanson J., Lowe S., Thomasson K., and *Porter J.E. 2006. Identification of Specific Amino Acids on the N-Terminus Domain of the Calcitonin-Like Receptor Critical for Interacting with the C-Terminus of the Calcitonin Gene-Related Peptide. BMC Pharmacol. 6:9.
16. Bough, K.J., Wetherington, J., Hassel, B., Pare, J.F., Gawryluk, J., Greene, J.G., Shaw, R., Smith, Y., Geiger, J.D., and R.J. Dingledine. 2006. Mitochondrial biogenesis induced by ketogenic diet in rat hippocampus. Annals Neurol. 60(2):223-35.
17. Chen, X., K. Pavlish, H.Y. Zhang and J.N. Benoit. 2006. Effects of chronic portal hypertension on agonist-induced actin polymerization in small mesenteric arteries. Am. J. Physiol. (Heart Circ. Physiol.) 290(5): H1915-21.
18. Relling, D.P., Esberg, L.B., Fang, C.X., Johnson, W.T., Murphy, E.J., Carlson, E.C., Saari, J.T., and Ren, J. 2006. High fat diet induced-obesity leads to cardiomyocyte dysfunction and upregulation of Foxo3a transcription factor independent of lipotoxicity and apoptosis J. Hypertension 24:549-561.
19. Sondag, CM and Combs, CK. 2006. Amyloid precursor protein cross-linking stimulates beta amyloid production and proinflammatory cytokine release in monocytic lineage cells. J. Neurochem. 97(2):449-461.
20. Hillman, KL, Doze, VA, Porter JE. 2007. Alpha1A-adrenergic receptors are functionally expressed by a subpopulation of cornu ammonis 1 interneurons in rat hippocampus. J. Pharmacol. Exp. Ther., 321(3):1062-8.
21. Jara, JH, Singh, BB, Floden, AM, and Combs, CK. 2007. Tumor necrosis factor alpha stimulates NMDA receptor activity in mouse cortical neurons resulting in ERK-dependent death. J Neurochem. 100:1407-1420.
22. Jurgens, CW, Hammad, HM, Lichter, JA, Boese SJ, Nelson, BW, Goldenstein, BL, Davis, KL, Xu, K, Hillman KL, Porter, JE, Doze VA. 2007. Alpha2A adrenergic receptor activation inhibits epileptiform activity in the rat hippocampal CA3 region. Mol. Pharmacol. 71(6):1572-81.
23. Kubatova, A, Honzatko, A, Brichac, J, Long, E, Picklo Sr., MJ. 2007. Analysis of HNE metabolism in CNS models, Redox Report 12 (12):16-19.
24. Relling, D.P., Esberg, L.B., Johnson, W.T., Murphy, E.J., Carlson, E.C., Saari, J.T., and Ren, J. 2007. Dietary interaction of high fat and marginal copper deficiency on cardic contractile function. Obesity, 15:1242-1257.
25. Woster, AW, Combs, CK. 2007. Differential ability of a thiazolidinedione PPAR? agonist to attenuate cytokine secretion in primary microglia and macrophage-like cells. J. Neurochem. 103:67-76.
26. Chen, X, Gawryluk, JW, Wagener, JF, Ghribi, O, and Geiger, JD. 2008. Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer’s disease. J. Neuroinflammation 3: 5-12.
27. Li S, Geiger JD, Lei S. 2008. Neurotensin enhances GABAergic activity in rat hippocampus CA1 region by modulating L-type calcium channels. J Neurophysiology, 99:2134-2143.
28. Long EK, Murphy TC, Leiphon LJ, Watt J, Morrow JD, Milne GL, Howard JRH, Picklo MJ. 2008. Trans-4-Hydroxy-2-hexenal is a neurotoxic product of docosahexaenoic (22:6; n-3) acid oxidation. Journal of Neurochemistry, 105(3):714-24.
29. Long EK, Smoliakova I, Honzatko A, and Picklo MJ. 2008. Structural Identification of a,ß-Unsaturated Aldehydes by GC/MS is Dependent upon Ionization Method. Lipids, 43(8):765-74.
30. Schrag, M, S Sharma, H Brown-Borg and O Ghribi. 2008. Hippocampus of Ames dwarf mice is resistant to b-amyloid-induced tau hyperphosphorylation and changes in apoptosis-regulatory protein levels. Hippocampus, 18(3):239-244.
31. Sharma, S, J Prasanthi, E Schommer, G Feist and O Ghribi. 2008. Hypercholesterolemia induced Ab accumulation in rabbit brain is associated with alteration in IGF-1 signaling. Neurobiol. Dis., 32(3):426-432.

BOOK CHAPTER:

Austin, S.A. and C. K. Combs. 2008. Mechanisms of Microglial Activation by Amyloid Precursor Protein and its Proteolytic Fragments. Book: Central Nervous System Diseases and Inflammation, eds: Thomas E. Lane, Monica Carson, Conni Bergmann and Tony Wyss-Coray. Springer Science and Business Media, LLC.

1. Anderson C.M., F. Lopez, H.Y. Zhang, K. Pavlish and J.N. Benoit. Altered mesenteric and uterine artery function in response to chronic reductions in utero-placental perfusion. FASEB J 2004;18:A633.
2. Barceló-Coblijn, G., Cinnamon, M., Jolly, C.A., and Murphy, E.J. Effects of dietary lipids on brain phospholipid composition. Am. Soc. Neurochem., August 14-18 2004, New York, NY, J. Neurochem. 90:DP3-03.
3. Barceló-Coblijn, G., Cinnamon, M., Jolly, C.A., and Murphy, E.J. Effects of dietary n-3 fatty acid on liver, heart, and brain phospholipid composition and phospholipid acyl chain mass. Brain Uptake and Utilization of Fatty Acids, Lipids, and Lipoproteins, October 1-9, 2004, Bethesda, MD.
4. Chen X., H.Y. Zhang, K. Pavlish, D. Machado-Arando, D.A. Dean and J.N. Benoit. Reduced vasoconstrictor function in portal hypertension: Role of small heat shock proteins. FASEB J 2004;18:A284.
5. Hillman K.L., Doze V.A. and Porter J.E.: Cell specific adrenergic receptor expression in the rat hippocampus. FASEB J., A964abs., 2004.
6. Hillman K.L., Doze V.A., Porter J.E.: Cell specific adrenergic receptor expression in the rat hippocampus. Frank Low Research Day, University of North Dakota School of Medicine & Health Sciences, p88, 2004.
7. Jurgens CWD, Porter JE, Doze VA. (2004) Adrenergic modulation of hippocampal epileptiform activity. FASEB Journal 18, A963.
8. Zhang H.Y., K. Pavlish, X. Chen, D. Machado-Arando, C. Anderson, D.A. Dean, and J.N. Benoit. Effect of portal hypertension on RhoA/Rho-kinase mediated vascular smooth muscle signaling transduction. FASEB J 2004;18:A307.
9. Chen X., K Pavlish, H.Y. Zhang and J.N. Benoit. Actin polymerization in mesenteric arterial smooth muscle in chronic portal hypertension. FASEB J 19(5): A1622, 2005.
10. Chen X., K Pavlish, H.Y. Zhang and J.N. Benoit. Down-regulation of HSP20 decreases agonist induced actin polymerization in vascular smooth muscle. FASEB J 2005; late-breaking abstract 4.
11. Gawryluk, J., M. Picklo, D. Patterson, J.D. Geiger. Behavioral abnormalities in Ts65Dn mice are accompanied by decreased levels of adenosine and adenylate nucleotides. Society for Neuroscience Meeting, Washington, D.C., November 2005.
12. Gawryluk, J.D. Geiger. HIV-1 Tat increases the production of neurotoxic substances in inflammatory cells independently of its direct cytotoxic actions on neurons. Society for Neuroscience Meeting, Washington, D.C., November 2005.
13. Jurgens C.W.D., Doze V.A. and Porter J.E.: ß adrenergic modulation of rat hippocampal network activity. FASEB J., 8975abs, 2005.
14. Ramonet, D., L. Buscemi, J. Gawryluk, P. Stevens, J.D. Geiger. Acidotic conditions are required for hypoxia-induced increases in neuronal BNIP3 expression but not cell death. Society for Neuroscience Meeting, Washington, D.C., November 2005.
15. Rau KE, Jurgens CWD, Hammad HM, Porter JE, Doze VA (2005) Adrenergic receptor expression in rat hippocampal CA3 pyramidal neurons using real time, single cell RT-PCR. Society for Neuroscience Abstracts.
16. Stevens, P., D. Ramonet, J. Gawryluk, L. Buscemi, J.D. Geiger. Creatine protects against HIV-1 protein Tat-induced increases in neuronal cell death and disruption of mitochondrial function. Society for Neuroscience Meeting, Washington, D.C., November 2005.
17. Woster, AP and Combs, CK. 2005. Thaizolidinedione PPAR? ligands do not inhibit the production of the proinflammatory cytokine TNF? in an in vitro microglia model. Soc. Neurosci. Abstr.
18. Zhang, H.Y., K.M. Pavlish, X. Chen, C.M. Anderson and J.N. Benoit. Rho-kinase and PKC in chronic portal hypertensive resistanct vasculature. FASEB J 19(5): A1622, 2005.
19. Anderson, C.M., H.M. Brown-Borg and W.T. Johnson. 2006. RhoA signal transduction: Effects of maternal copper deficiency on progeny. DOHaD Amsterdam, The Netherlands. Sept. 13-16.
20. Austin, S.A., Floden, A.M., Nussbaum, R.L., Murphy, E.J., and Combs, C.K. Alpha-synuclein expression regulates microglial activation phenotype. Am. Soc. Neurochem., March 11-15, 2006, Portland, OR, J. Neurochem. 96(Suppl.1):LB-5.
21. Austin, SA, and Combs, CK. 2006. Amyloid precursor protein and beta amyloid peptide immunoreactivity increases in endothelial cells of human and mouse atherosclerotic aorta. Soc. Neurosci.Abstr.
22. Brichac J, Honzatko A, Long E, and Picklo MJ. Analysis of HNE and its Metabolites: Chiral and LC-ESI-MS/MS Applications. HNE Club. Genoa, Italy. June 2006.
23. Chen, X, K. Pavlish and J.N. Benoit. Myosin triggers actin polymerization in vascular smooth muscle. FASEB J (2006).
24. Combs, CK. Jara, JJ, Nagamoto-Combs, K, Floden, AM. 2006. Tumor necrosis factor alpha stimulates activation of microglia and increased expression of its low affinity receptor. Soc. Neurosci.Abstr.
25. Duncan, M.W., S. Hunsucker, B. Solomon, J. Gawryluk, J.D. Geiger, G.N. Vacano and D. Patterson. Post-Mortem Events in the Brain Studied by Proteomic Methods. 2006 World Down’s Syndrome Congress, Vancouver, Canada, August, 2006.
26. Gawyrluk, J.W., K.J. Bough, J. Wetherington, D.A. Knorr, R.J. Dingledine and J.D. Geiger. Ketogenic Diet Increases Seizure Threshold and Levels of High-Energy Brain Metabolites in Rat. Amer. Soc. Neurochem. Portland, Oregon, March 2006
27. Hammad H.M., Hillman K.L., Porter J.E. and Doze V.A.: Adrenergic Receptor Expression in Rat Hippocampal CA3 Pyramidal Neurons Using Real Time, Single Cell RT-PCR. FASEB J., 2715abs., 2006.
28. Hillman KL, Doze VA, Porter JE (2006) a adrenergic activation of GABAergic interneurons in region CA1 of the rat hippocampus. FASEB Journal.
29. Hillman KL, Doze VA, Porter JE (2006) Norepinephrine exictes a subset of CA1 hippocampal interneurons via an a1A adrenergic receptor. 1st North American Regional Epilepsy Conference, American Epilepsy Society Abstr #117.
30. Jara, JH, Singh, BB, Combs, CK. 2006. Tumor necrosis factor alpha potentiates NMDA receptor dependent neuron death in an age dependent fashion in vitro. Soc. Neurosci. Abstr.
31. Li, S. and Lei, S. (Porter J.E., ASPET sponsor): Neurotensin Facilitates GABA Release in Rat Hippocampus. FASEB J., 1956abs., 2006.
32. Ramonet, D., L. Buscemi, J.W. Gawryluk and J.D. Geiger. The role of BNIP3, Mitochondrial Dysfunction and Intracellular pH in Hypoxia-Induced Neuronal Cell Death. NISBRE, Washington DC, July 2006.
33. Rau K.E., Jurgens C.W.D., Hammad H.M., Porter J.E. and Doze V.A.: Adrenergic Receptor Expression in Rat Hippocampal CA3 Pyramidal Neurons using real time, single cell RT-PCR. J. Neurosci. Abs., 2006.
34. Sharma, S., O. Ghribi and J.D. Geiger. Caffeine prevents cholesterol-induced b-amyloid overproduction and tau hyperphosphorylation in rabbit hippocampus. NISBRE, Washington DC, July, 2006.
35. Sharma, S., O Ghribi and JD Geiger. Caffeine prevents cholesterol-induced ß-amyloid overproduction and tau hyperphosphorylation in rabbit hippocampus. Society for Neuroscience, 36th Annual Meeting in Atlanta, GA, October 14-18, 2006.
36. Stevens, P., J.W. Gawryluk, D. Ramonet, L. Buscemi, and J.D. Geiger. Creatine Protects Against HIV-1 Tat-Induced Increases in Neuronal Cell Death and Disruption of Mitochondrial Function. IUPHAR, Bejing, China, July 2006.
37. Stevens, P., J.W. Gawryluk, D. Ramonet, L. Buscemi, and J.D. Geiger. Creatine Protects Against HIV-1 Tat-Induced Increases in Neuronal Cell Death and Disruption of Mitochondrial Function. NISBRE, Washington DC, July 2006.
38. Davis, KL, Lichter, JA, Nelson, BW, Goldenstein, BL, Boese, SJ, Pribula, JA, O’Brien, JJ, Xu, K, Sickler, TA, Green, KM, Jurgens, CW, Porter, JE, Doze, VA (2007) Alpha-2A adrenergic receptor activation inhibits rat hippocampal CA3 network activity. Experimental Biology, Washington, D.C.
39. Gawryluk J.W., Wagener J.F., Masino S.A., and Geiger J.D. Effects of ketogenic diet on levels of high-energy brain metabolites. International Society for Neurochemistry, Cancun, Mexico, August 2007.
40. Green, KM, Boese, SJ, Xu, K, Nelson, BW, Goldenstein, BL, Davis, KL, Lichter, JA, Pribula, JA, O’Brien, JJ, Johnson, JA, Jurgens, CW, Porter, JE, Doze VA (2007) Actions of alpha adrenergic receptor agonists on rat hippocampal CA3 network activity. Experimental Biology, Washington, D.C.
41. Grisanti L.A., Rojanathammanee L. and Porter J.E.: ß-Arrestin/HSP27 Complex Produces Anti-Apoptotic Effects Through Specific ß-Adrenergic Receptor Subtype. J. Neurosci. Abs., 2007.
42. Hillman, KL, Doze, VA, Porter, JE (2007)alA-adrenergic receptor activation modulates pyramidal neuron excitability in CA1 hippocampus. Experimental Biology, Washington, D.C.
43. Jurgens, CW, Doze, VA (2007) Norepinephrine inhibits hippocampal epileptiform activity via a distinct and localized CA3 recurrent mechanism. Experimental Biology, Washington, D.C.
44. Long EK and Picklo MJ. Analysis of Structural Differences Between 4-Hydroxy-2-Alkenals and 2-Alkenals Using Electron Impact and Positive-Ion Chemical Ionization Mass Spectrometry Following Derivatization With O-(2,3,4,5,6-Pentafluorobenzyl)-Hydroxylamine. American Oil Chemists Society, Quebec, Canada, May 2007.
45. Long EK, Murphy TC, Leiphon LJ, Watt J, Morrow JD, Milne GL, Howard JRH, Picklo MJ. Trans-4-Hydroxy-2-hexenal is a neurotoxic product of docosahexaenoic (22:6; n-3) acid oxidation. Society for Free Radical Biology and Medicine. Washington DC, November 2007.
46. Masino S.A., Gockel J.A., Pomeroy L.T., Wasser C.A., Wagener J.F., Gawryluk J.W., and GeigJ.D. A link between metabolism and excitability: upregulation of purines with a ketogenic diet. American Epilepsy Society, Philadelphia, December 2007.
47. Sharma S, and Ghribi O. Hypercholesterolemia-induced alteration in insulin signaling:Implications in a model for sporadic Alzheimer’s Disease. Society for Neuroscience, 37th Annual Meeting in San Diego, CA, Febr 2007.
48. Xu, K, Hillman, KL, Hammad, HM, Jurgens, CW, Goldenstein, BL, Johnson, JA, Porter, JE, Doze, VA (2007) Adrenergic receptor characterization of rat hippocampal neurons using real time single cell RT_PCR. Experimental Biology, Washington, D.C.
49. Goldenstein B, Jurgens C, Knudson C, Lichter J, Carr P, Perez D, Doze V (2008) Alpha-1 adrenergic receptor regulation of seizures and neurodegeneration. Experimental Biology (APS), April 5-9, San Diego, CA.
50. Goldenstein B, Nelson B, Xu K, Pribula J, wald J, Weinshenker D, Charnebeau R, Huang X, Neubig R, Doze V (2008) RGS protein suppression of Gao protein-mediated a2A-adrenergic inhibition of mouse hippocampal CA3 epileptiform activity. Experimental Biology, American Society for Pharmacology & Experimental Therapeutics (ASPET) 3rd RGS Colloquium, April 3-4, San Diego, CA (see http://aspet.org/public/meetings/RGS_08.htm).
51. Goldenstein BL, Nelson BW, Xu K, Luger EJ, Pribula JA, Wald JM, Meberg PJ, Weinshenker D, Doze VA (2008) Alpha2A adrenergic receptor-mediated inhbition of mouse hippocampal CA3 epileptiform activity. Society for Neuroscience Abstracts #629.20, Washington, D.C.
52. Jurgens C, Doze VA (2008) a2A adrenergic receptors modulate CA3-CA3 pyramidal cell communication in the rat hippocampuys. Experimental Biology (ASPET) Meeting, April 5-9, San Diego, CA.
53. Luger E, Davis K, Goldenstein B, Nelson B, Xu K,m Pribula J, Wald J, Weinshenker D, Doze V (2008) Alpha2A adrenergic receptor-mediated inhibition of mouse hippocampal CA3 network activity. Experimental Biology (APS), April 5-9, San Diego, CA.
54. Masino S.A., Gockel J.A., Pomeroy L.T., Wasser C.A., Wagener J.F., Gawryluk J.W., and Geiger J.D. A link between metabolism and excitability: upregulation of purines with a ketogenic diet. American Epilepsy Society, Philadelphia, December 2007.
55. Austin, S.A., Murphy, E.J., and Combs, C.K. Elevated PLD-mediated signaling contributes to the elevated basal reactivity in ?-synuclein -/- microglia. Am. Soc. Neurochem., March 1-5, 2008, San Antonio, TX, J. Neurochem. 104:PTW04-01.
56. Nelson B, Xu K, Goldenstein B, Pribula J, Luger E, Wald J, O’Shea L, Charbeneau R, Huang X, Neubig R, Doze V (2008) Gao proteins regulate the a2A adrenergic receptor-mediated inhibitory effects of epinephrine in the mouse hippocampal CA3 region. Experimental Biology (ASBMB), April 5-9, San Diego, CA.
57. Nelson BW, Goldenstein BL, Xu K, Luger EJ, Pribula JA, Wald JM, O’Shea LA, Charbeneau RA, Huang X, Neubig RR, Doze VA (2008) RGS protein suppression of Gao protein-mediated a2A-adrenergic inhbition of mouse hippocampal CA3 epileptiform activity. Society for Neuroscience
Abstracts #629.29, Washington, D.C.
58. O’Shea L, Boese S, Xu K, Nelson B, Goldenstein B, Pribula J, O’Brein J, Davis K, Laverdure F, Schulte C, Schlosser D, Luger E, Jurgens C, Porter J, Doze V (2008) Efficacy and potency of alpha adrenergic receptor agonists at inhibiting rat hippocampal CA3 network activity. Experimental Biology (APS) Meeting, April 5-9, San Diego, CA.
59. Pribula J, Boese S, Xu K, Nelson B, Goldenstein B, O’Shea L, O’Brien J, Davis K, Laverdure F, Schulte C, Green K, Schlosser D, Luger E, Lichter J, Jurgens C, Porter J, Doze V (2008) Alpha-2A adrenergic receptor activation inhibits rat hippocampal CA3 network activity. Experimental Biology (ASBMB) Meeting, April 5-9, San Diego, CA.
60. Pribula JA, Boese SJ, Xu K, Nelson BW, Goldenstein BL, O’Shea LA, Jasmine O’Brien, Davis KL, Laverdure F, Schulte C, Green KM, Schlosser DD, Luger EJ, Lichter JA, Jurgens CWD, Porter JE, Doze VA (2008) Alpha-2A adrenergic receptor activation inhibits rat hippocampal CA3 network activity. Frank Low Research Day, University of North Dakota – Grand Forks, ND.
61. Xu K, Goldenstein BL, Nelson BW, Luger EJ, Pribula JA, Wald JM, Weinshenker D, Charbeneau RA, Huang X, Neubig RR, Doze VA (2008) RGS protein suppression of Gao protein-mediated a2A adrenergic inhibition of mouse hippocampal CA3 epileptiform activity. Berlin Neuroscience Forum, June 5-7, 2008, Liebenwalde, Germany (see http://bnf2008.glia.mdc-berlin.de/general.html).
62. Xu K, Nelson B, Goldenstein B, Luger E, Charbeneau R, Huang X, Neubig R, Doze V (2008) a2A adrenergic receptor-mediated antiepileptic effects via Gao proteins. Experimental Biology (ASPET) Meeting, April 5-9, San Diego, CA.

Austin, S.
2008 2nd Place Graduate Student Oral Presentation, North Dakota Academy of Science
2008 Honorable Mention Poster Presentation, Frank Low Research Day, University of North Dakota
2007-2008 EPSCoR Red River Initiative Graduate Student Fellow
2007 CWIN Travel Award Fellowship, Society for Neuroscience
2007 ISN/ASN Travel Award
2007 Office of Research, Development and Compliance Travel Award
2006 Intercollegiate Academic Funding Award, University of North Dakota
2006 Office of Research, Development and Compliance Travel Award

Gawrulyk, J.
2007 EPSCoR Red River Initiative Graduate Student Fellow
2006 EPSCoR Red River Initiative Graduate Student Fellow

Hillman, K.
2007 Doctoral Dissertation Assistantship EPSCoR
2006 Intercollegiate Academic Funding Award, University of North Dakota
2006 Doctoral Dissertation Assistantship EPSCoR
2005 Pre-doctoral Research Fellowship, Epilepsy Foundation

Jara, J.
2007 Dr. Surendra Parmar Travel Award
2007 Honarable Mention Poster Presentation, Frank Low Resesarch Day, University of North Dakota
2006 Intercollegiate Academic Funding Award, University of North Dakota
2006 Research, Development and Complicance Travel Award

Jurgens, C.
2008 Doctoral Dissertation Assistantship EPSCoR
2007 Doctoral Dissertation Assistantship EPSCoR
2006 Office of Research, Development and Compliance Travel Award
2006 Pre-doctoral Award from the Epilepsy Foundation
2006 ASPET Travel Award

Long, E.K.
2007 Dr. Surendra Parmar Travel Award

Sharma, S.
2008 Summer Doctoral Fellowship, University of North Dakota Graduate School
2007 Honorable Mention Poster Presentation, Frank Low Research Day, University of North Dakota
2007 Travel Award to Attend Society for Neuroscience meeting
2006 Travel Award to Attend Society for Neuroscience meeting
2006 Intercollegiate Academic Funding Award, University of North Dakota

WHERE ARE THEY NOW?

Austin, S.: Pre-doctoral Fellow, National Center for Drug Discovery in Neurodegeneration, Laboratory for Drug Discovery in Neurodegeneration, Harvard NeuroDiscovery Center, Cambridge, MA.

Hillman, K.: Post-doctoral Fellow at the Marsden Foundation of New Zealand.

Jara, J.: Post-doctoral Fellow at Northwestern University, Chicago, IL.

Li, S.: Research Associate in the Center for Neuroscience Research at National Children’s Hospital in Washington, DC.

Woster, A.: Assistant Professor, Department of Psychology, South Dakota State University.